We are live on ! Find out more
MGNX icon

MacroGenics
MGNX

132 hedge funds and large institutions have $835M invested in MacroGenics in 2016 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 36 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,075% more call options, than puts

Call options by funds: $2.77M | Put options by funds: $236K

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

31% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 36

10% more capital invested

Capital invested by funds: $760M → $835M (+$75.2M)

6% more funds holding

Funds holding: 125 → 132 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
132
Holders Change
+7
Holders Change %
+5.6%
% of All Funds
3.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
47
Reduced
36
Closed
9
Calls
$2.77M
Puts
$236K
Net Calls
+$2.54M
Net Calls Change
+$1.81M

Top Buyers

Rank Fund Capital Flow
1
BB
BB Biotech
Switzerland
+$27.8M
2
HRCM
Hood River Capital Management
Florida
+$5.63M
3
AG
Artal Group
Luxembourg
+$4.46M
4
SIM
Spark Investment Management
New York
+$3.71M
5
Millennium Management
Millennium Management
New York
+$3.59M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$22.1M
2
Federated Hermes
Federated Hermes
Pennsylvania
-$13.1M
3
BI
BVF Inc
California
-$5.4M
4
O
OrbiMed
New York
-$4.03M
5
JP Morgan Chase
JP Morgan Chase
New York
-$3.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$149M -$64.5K -2,170 -0%
O
2
OppenheimerFunds
New York
$89.8M +$600K +20,160 +0.7%
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$54.2M -$22.1M -741,600 -29%
BB
4
BB Biotech
Switzerland
$43.5M +$27.8M +935,000 +180%
BRC
5
Blue Ridge Capital
New York
$40.7M – – –
BFA
6
BlackRock Fund Advisors
California
$40.2M +$2.08M +69,938 +5%
Vanguard Group
7
Vanguard Group
Pennsylvania
$38.8M +$177K +5,957 +0.5%
State Street
8
State Street
Massachusetts
$24.9M +$3.43M +115,323 +16%
BIT
9
BlackRock Institutional Trust
California
$22.4M +$890K +29,937 +4%
EAM
10
Eventide Asset Management
Massachusetts
$21.7M – – –
CAM
11
Cormorant Asset Management
Massachusetts
$21.2M – – –
PA
12
Pinnacle Associates
New York
$20.9M -$426K -14,320 -2%
Franklin Resources
13
Franklin Resources
California
$17.9M – – –
UBS AM
14
UBS AM
Illinois
$15.7M -$912K -30,673 -6%
EA
15
Emerald Advisers
Pennsylvania
$12.3M +$1.45M +48,799 +14%
SIM
16
Spark Investment Management
New York
$11.7M +$3.71M +124,800 +47%
Northern Trust
17
Northern Trust
Illinois
$11.4M +$157K +5,264 +1%
BBA
18
Baker Bros. Advisors
New York
$10.9M – – –
EMFAT
19
Emerald Mutual Fund Advisers Trust
Pennsylvania
$10.7M +$1.11M +37,190 +12%
EAM
20
EverPoint Asset Management
Connecticut
$8.97M -$2.97M -100,000 -25%
TM
21
Tiger Management
New York
$7.96M -$1.4M -47,073 -15%
Federated Hermes
22
Federated Hermes
Pennsylvania
$7.72M -$13.1M -441,524 -63%
TA
23
Teachers Advisors
New York
$7.29M – – –
Geode Capital Management
24
Geode Capital Management
Massachusetts
$6.73M +$93.8K +3,155 +1%
RSCM
25
Rock Springs Capital Management
Maryland
$6.73M – – –
1
2 3 4 5

MGNX Hedge Fund Activity: Q3 2016 in Review

132 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q3 2016, worth a combined $835M — up 9.9% from $760M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new MGNX positions and 9 closed out — a net gain of 8 holders — while 47 added to existing stakes and 36 trimmed.

The largest buyer was BB Biotech, adding an estimated $27.8M. The largest seller was Point72 Asset Management, cutting an estimated $22.1M.

  • 132 institutional investors held MacroGenics (MGNX) as of Q3 2016, up from 125 in Q2 2016.
  • Funds reported $835M of MacroGenics stock for Q3 2016, up 9.9% quarter-over-quarter.
  • 17 funds opened new MacroGenics positions in Q3 2016 and 9 closed out, a net change of +8 holders.
  • The largest MacroGenics buyer in Q3 2016 was BB Biotech, an estimated $27.8M added.
  • The largest MacroGenics seller in Q3 2016 was Point72 Asset Management, an estimated $22.1M sold.

Based on aggregated 13F filings for Q3 2016.